Navi Mumbai, India
Navi Mumbai, India

Time filter

Source Type

Patent
GLENMARK PHARMACEUTICALS Ltd | Date: 2014-12-23

The present invention relates to a dry powder inhaler for administering a medicament via oral inhalation route to a subject. Particularly, the dry powder inhaler according to present invention is suitable for delivering accurate doses of a medicament in different ranges of inspiratory capacity of the subject.


Patent
Glenmark Pharmaceuticals Ltd | Date: 2015-03-18

The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.


Patent
GLENMARK PHARMACEUTICALS Ltd | Date: 2014-03-21

Disclosed is a process for the preparation of rivaroxaban and purifying rivaroxaban.


Patent
Glenmark Pharmaceuticals Ltd | Date: 2014-10-03

The present patent application relates to a method of treating allergic rhinitis in a subject (preferably a human) by administering a combination of mometasone or its salt and olopatadine or its salt.


Patent
Glenmark Pharmaceuticals Ltd | Date: 2015-04-08

The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a human) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.


Patent
Glenmark Pharmaceuticals Ltd | Date: 2014-05-15

Provided is an improved process for the preparation of arformoterol L-(+)-tartrate, and more specifically provided is a novel process for the preparation of arformoterol L-(+)-tartrate via arformoterol D-()-tartrate.


Patent
Glenmark Pharmaceuticals Ltd | Date: 2014-05-20

Provided is a novel process for the preparation of alogliptin.


Patent
Glenmark Pharmaceuticals Ltd | Date: 2014-09-11

The present invention relates to a stable fixed dose aqueous pharmaceutical composition (e.g., contained in a container) for nasal administration to a human, comprising mometasone or its salt, olopatadine or its salt. The composition may further include a hydrocolloid. The invention also relates to a process for preparing the pharmaceutical composition, and the use of the pharmaceutical composition in the treatment of rhinitis in a subject.


Patent
Glenmark Pharmaceuticals Ltd | Date: 2014-01-30

The present invention provides process for the preparation of ivacaftor and solvates thereof.


Patent
Glenmark Pharmaceuticals Ltd | Date: 2014-05-30

The present invention relates to a pre-lyophilized composition comprising bendamustine or its pharmaceutically acceptable salt, a pharmaceutically acceptable carrier, an organic solvent and water. Furthermore, the present invention provides a stable pharmaceutical composition comprising bendamustine hydrochloride prepared from such pre-lyophilized composition, a process for preparing such composition; and its use in the treatment of cancer.

Loading Glenmark Pharmaceuticals Ltd. collaborators
Loading Glenmark Pharmaceuticals Ltd. collaborators